The University of Arizona Cancer Center will receive $1.4 million as a collaborating center with the national network of academic, public health and community partners, working together to reduce the burden of cancer, especially among Hispanic cancer survivors.Continue reading
Category Archives: AZBio News
BIO Hosts Two-Day Virtual Research Summit on COVID-19 Response Efforts
Participants at the virtual summit included invited leaders from 45 biotech and pharmaceutical companies, global experts in virology and immunology, and government officials, including Ambassador Deborah Birx and Dr. Robert Kadlec, who provided great insights with regards to the government’s coronavirus effort.
Dignity Health St. Joseph’s adopts innovative app to keep patients, medical staff and caregivers connected during COVID-19 pandemic
App from Medical Memory is a virtual solution to hospital visitor restrictions.Continue reading
Additional Warnings Issued for COVID-19 Possible Treatments
In the last 48-hours, there have been multiple reports warning the public about the medicines being tested as possible treatments for COVID-19. See below:
- Chloroquine treats malaria: Will it work against coronavirus? The side effects are risky, experts say
- AZ Couple took chloroquine phosphate – Man died; Woman in ICU
- Virus Drug Touted by Trump, Musk Can Kill With Just Two Gram Dose
- Which Covid-19 drugs work ? The first medical reports are in, but there’s no silver bullet for coronavirus infection yet.
At this time, there is no drug treatment that has been found to be effective in patients with COVID-19 and none has been approved by regulatory agencies to treat COVID-19. Several antivirals (including favipiravir, remdesivir, umifenovir and lopinavir/ritonavir) and antiinflammatory drugs (azithromycin) and antimalarials (chloroquine and hydroxychloroquine) are now being tested in clinical research for their potential benefit. Chloroquine, hydroxychloroquine and azithromycin) are known to prolong QTc and can cause potentially lethal arrhythmias (TdP). The combination of lopinavir and ritonavir is known to cause QT prolongation and is being followed to see if it also is associated with TdP arrhythmias.
Health Analytics Firm Heads Up Releases Health Tracking Dashboard to Enable Home Monitoring During COVID-19
Applying digital health technology to facilitate self-monitoring, remote diagnostics and reducing strain on hospital systems.Continue reading
Helping Others: Banner Health employees volunteer to make masks for frontline staff
Handmade masks aim to preserve supply of personal protective equipmentContinue reading
Industry Welcomes Government Direction On Allocation of Ventilators
Collaboration With FEMA Would Speed Delivery To Patients Where Needed MostContinue reading
Banner Health experts warn against self-medicating to prevent or treat COVID-19
PHOENIX (March 23, 2020) – Medical toxicologists and emergency physicians are warning the public against the use of inappropriate medications and household products to prevent or treat COVID-19. In particular, Banner Health experts emphasize that chloroquine, a malaria medication, should not be ingested to treat or prevent this virus.Continue reading
Genentech Announces FDA Approval of Clinical Trial for Actemra to Treat Hospitalized Patients With Severe COVID-19 Pneumonia
Genentech will also provide 10,000 vials of Actemra to the U.S. Strategic National Stockpile
Current U.S. supply of Actemra for approved indications is not expected to be impactedContinue reading